Skip to main content

Table 2 Complications and uncommon clinical manifestations of norovirus infection in 2004–2012 in northern Taiwan

From: Complicated norovirus infection and assessment of severity by a modified Vesikari disease score system in hospitalized children

% Symptoms

2004/2005 winter (N = 35)

2006/2007 winter (N = 75)

P -value b

2008/09/10 winter (N = 36)

P-value

2011/12 winter (N = 43)

P-value

Abdominal pain or irritability

22.9 (8)

21.3 (16)

0.937

41.7 (15)

0.033

44.2 (19)

0.014

GI Hemorrhage (gross and occult blood in stool)

8.6 (3)

14.7 (11)

0.217

22.2 (8)

0.047

23.3 (10)

0.030

Electrolyte imbalance

14.3 (5)

13.3 (10)

0.984

8.5 (3)

0.475

11.6 (5)

0.816

Fever >38 °C

37.1 (13)

36 (27)

0.814

25 (9)

0.208

62.8 (27)

0.015

High fever >39 °C

8.6 (3)

9.3 (7)

0.722

13.8 (5)

0.330

34.9 (15)

0.001

Convulsion

2.9 (1)

28 (21)

<0.001

2.8 (1)

0.798

9.3 (4)

0.266

Hypotension

5.7 (2)

6.7 (5)

0.817

5.5 (2)

0.983

4.6 (2)

0.825

Hypoglycemia

11.4 (4)

20 (15)

0.316

8.5 (3)

0.475

6.9 (3)

0.320

Disease severity score > 10 (severe)

22.9 (8)

26.6 (20)

0.604

30.6 (11)

0.403

23.3 (10)

0.943

Modified severity score > 11 (severe)

28.5 (10)

32 (24)

0.643

33.3 (12)

0.572

30.2 (13)

0.748

Predominant genotype/subgenotype,

No. (%)a

ND

GII.4 2006b,

(Den_Haag)

28 of 70 (40 %)

 

GII.4 2010,

(New Orleans)

16 of 33 (48.5 %)

 

GII.4 Sydney,

11 of 37 (29.7 %)

GII.4 2012b,

10 of 37 (27 %)

 
  1. a Percentage of dominant strains in samples available for sub-genotype analysis
  2. b P-value means statistical results of compariing each item in later year period to those in the earlier years of 2004–2005